Sign in or Register   Sign in or Register
  |  

Mouse Anti-KCNB1 Recombinant Antibody (S89-34) (CBMAB-K0508-LY)

This product is antibody recognizes KCNB1. The antibody S89-34 immunoassay techniques such as: IHC, IF, EM, IP, WB.
See all KCNB1 antibodies
Published Data

Summary

Host Animal
Mouse
Specificity
Rat, Human, Mouse
Clone
S89-34
Antibody Isotype
IgG1
Application
IHC, IF, EM, IP, WB

Basic Information

Immunogen
Kv2.1 Antibody was produced in mice by repeated immunizations raised against a synthetic peptide corresponding to the cytoplamsic C-terminus region of rat KV2.1
Specificity
Rat, Human, Mouse
Antibody Isotype
IgG1
Clonality
Monoclonal
Application Notes
The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Format
Liquid
Concentration
1 mg/mL
Purity
> 95% Purity determined by SDS-PAGE.
Storage
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freezethaw cycles.

Target

Full Name
Potassium Voltage-Gated Channel Subfamily B Member 1
Introduction
Voltage-gated potassium (Kv) channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. Four sequence-related potassium channel genes - shaker, shaw, shab, and shal - have been identified in Drosophila, and each has been shown to have human homolog(s). This gene encodes a member of the potassium channel, voltage-gated, shab-related subfamily. This member is a delayed rectifier potassium channel and its activity is modulated by some other family members. [provided by RefSeq, Jul 2008]
Entrez Gene ID
Human3745
Mouse16500
Rat25736
UniProt ID
HumanQ14721
MouseQ03717
RatP15387
Alternative Names
Shab; Kv2.1; DRK1PC; Kcr1-1
Function
Voltage-gated potassium channel that mediates transmembrane potassium transport in excitable membranes, primarily in the brain, but also in the pancreas and cardiovascular system. Contributes to the regulation of the action potential (AP) repolarization, duration and frequency of repetitive AP firing in neurons, muscle cells and endocrine cells and plays a role in homeostatic attenuation of electrical excitability throughout the brain (PubMed:23161216).
Plays also a role in the regulation of exocytosis independently of its electrical function (By similarity).
Forms tetrameric potassium-selective channels through which potassium ions pass in accordance with their electrochemical gradient. The channel alternates between opened and closed conformations in response to the voltage difference across the membrane. Homotetrameric channels mediate a delayed-rectifier voltage-dependent outward potassium current that display rapid activation and slow inactivation in response to membrane depolarization (PubMed:8081723, PubMed:1283219, PubMed:10484328, PubMed:12560340, PubMed:19074135, PubMed:19717558, PubMed:24901643).
Can form functional homotetrameric and heterotetrameric channels that contain variable proportions of KCNB2; channel properties depend on the type of alpha subunits that are part of the channel (By similarity).
Can also form functional heterotetrameric channels with other alpha subunits that are non-conducting when expressed alone, such as KCNF1, KCNG1, KCNG3, KCNG4, KCNH1, KCNH2, KCNS1, KCNS2, KCNS3 and KCNV1, creating a functionally diverse range of channel complexes (PubMed:10484328, PubMed:11852086, PubMed:12060745, PubMed:19074135, PubMed:19717558, PubMed:24901643).
Heterotetrameric channel activity formed with KCNS3 show increased current amplitude with the threshold for action potential activation shifted towards more negative values in hypoxic-treated pulmonary artery smooth muscle cells (By similarity).
Channel properties are also modulated by cytoplasmic ancillary beta subunits such as AMIGO1, KCNE1, KCNE2 and KCNE3, slowing activation and inactivation rate of the delayed rectifier potassium channels (By similarity).
In vivo, membranes probably contain a mixture of heteromeric potassium channel complexes, making it difficult to assign currents observed in intact tissues to any particular potassium channel family member. Major contributor to the slowly inactivating delayed-rectifier voltage-gated potassium current in neurons of the central nervous system, sympathetic ganglion neurons, neuroendocrine cells, pancreatic beta cells, cardiomyocytes and smooth muscle cells. Mediates the major part of the somatodendritic delayed-rectifier potassium current in hippocampal and cortical pyramidal neurons and sympathetic superior cervical ganglion (CGC) neurons that acts to slow down periods of firing, especially during high frequency stimulation. Plays a role in the induction of long-term potentiation (LTP) of neuron excitability in the CA3 layer of the hippocampus (By similarity).
Contributes to the regulation of glucose-induced action potential amplitude and duration in pancreatic beta cells, hence limiting calcium influx and insulin secretion (PubMed:23161216).
Plays a role in the regulation of resting membrane potential and contraction in hypoxia-treated pulmonary artery smooth muscle cells. May contribute to the regulation of the duration of both the action potential of cardiomyocytes and the heart ventricular repolarization QT interval. Contributes to the pronounced pro-apoptotic potassium current surge during neuronal apoptotic cell death in response to oxidative injury. May confer neuroprotection in response to hypoxia/ischemic insults by suppressing pyramidal neurons hyperexcitability in hippocampal and cortical regions (By similarity).
Promotes trafficking of KCNG3, KCNH1 and KCNH2 to the cell surface membrane, presumably by forming heterotetrameric channels with these subunits (PubMed:12060745).
Plays a role in the calcium-dependent recruitment and release of fusion-competent vesicles from the soma of neurons, neuroendocrine and glucose-induced pancreatic beta cells by binding key components of the fusion machinery in a pore-independent manner (By similarity).
Biological Process
Action potentialManual Assertion Based On ExperimentIDA:UniProtKB
Cellular response to glucose stimulusISS:UniProtKB
Cellular response to nutrient levelsISS:UniProtKB
Glucose homeostasisISS:UniProtKB
Glutamate receptor signaling pathwayISS:UniProtKB
Negative regulation of insulin secretionISS:UniProtKB
Positive regulation of calcium ion-dependent exocytosisISS:UniProtKB
Positive regulation of catecholamine secretionISS:UniProtKB
Positive regulation of long-term synaptic depressionISS:UniProtKB
Positive regulation of norepinephrine secretionISS:UniProtKB
Positive regulation of protein targeting to membraneManual Assertion Based On ExperimentIDA:UniProtKB
Potassium ion export across plasma membraneIEA:Ensembl
Potassium ion transmembrane transportManual Assertion Based On ExperimentIDA:UniProtKB
Protein homooligomerizationIEA:InterPro
Protein localization to plasma membraneISS:UniProtKB
Regulation of action potentialISS:UniProtKB
Regulation of ion transmembrane transportIEA:UniProtKB-KW
Regulation of motor neuron apoptotic processISS:UniProtKB
Vesicle docking involved in exocytosisISS:UniProtKB
Cellular Location
Cell membrane; Perikaryon; Cell projection, axon; Cell projection, dendrite; Membrane; Cell junction, synapse, postsynaptic cell membrane; Cell junction, synapse; Cell junction, synapse, synaptosome; Lateral cell membrane; Cell membrane, sarcolemma. Localizes to high-density somatodendritic clusters and non-clustered sites on the surface of neocortical and hippocampal pyramidal neurons in a cortical actin cytoskeleton-dependent manner (PubMed:24477962).
Localizes also to high-density clusters in the axon initial segment (AIS), at ankyrin-G-deficient sites, on the surface of neocortical and hippocampal pyramidal neurons (PubMed:24477962).
KCNB1-containing AIS clusters localize either in close apposition to smooth endoplasmic reticulum cisternal organelles or with GABA-A receptor-containing synapses of hippocampal and cortical pyramidal neurons, respectively (PubMed:24477962).
Localizes to high-density clusters on the cell surface of atrial and ventricular myocytes and at the lateral plasma membrane in epithelial cells. Localizes both to the axial and transverse tubules (T tubule) and sarcolemma in ventricular myocytes. Associated with lipid raft domains. In cortical neurons, apoptotic injuries induce de novo plasma membrane insertion in a SNARE-dependent manner causing an apoptotic potassium current surge.
Involvement in disease
Developmental and epileptic encephalopathy 26 (DEE26):
A form of epileptic encephalopathy, a heterogeneous group of severe early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. DEE26 patients manifest multiple types of seizures, delayed psychomotor development, poor or absent speech, hypotonia, hypsarrhythmia.
Topology
Cytoplasmic: 1-186
Helical: 187-208
Extracellular: 209-228
Helical: 229-250
Cytoplasmic: 251-259
Helical: 260-280
Extracellular: 281-294
Helical: 295-316
Cytoplasmic: 317-330
Helical: 331-351
Extracellular: 352-364
Helical: 365-384
Extracellular: 385-391
Helical: 392-420
Cytoplasmic: 421-858
PTM
Phosphorylated. Differential C-terminal phosphorylation on a subset of serines allows graded activity-dependent regulation of channel gating in hippocampal neurons. Ser-607 and Tyr-128 are significant sites of voltage-gated regulation through phosphorylation/dephosphorylation activities. Tyr-128 can be phosphorylated by Src and dephosphorylated by cytoplasmic form of the phosphatase PTPRE. CDK5-induced Ser-607 phosphorylation increases in response to acute blockade of neuronal activity. Phosphorylated on Tyr-128 by Src and on Ser-805 by MAPK14/P38MAPK; phosphorylations are necessary and sufficient for an increase in plasma membrane insertion, apoptotic potassium current surge and completion of the neuronal cell death program. Phosphorylated on Ser-520, Ser-607, Ser-656 and Ser-805 by CDK5; phosphorylation is necessary for KCNB1 channel clustering formation. The Ser-607 phosphorylation state differs between KCNB1-containing clusters on the proximal and distal portions of the axon initial segment (AIS). Highly phosphorylated on serine residues in the C-terminal cytoplasmic tail in resting neurons. Phosphorylated in pancreatic beta cells in response to incretin hormones stimulation in a PKA- and RPS6KA5/MSK1-dependent signaling pathway, promoting beta cell survival. Phosphorylation on Ser-567 is reduced during postnatal development with low levels at P2 and P5; levels then increase to reach adult levels by P14. Phosphorylation on Ser-457, Ser-541, Ser-567, Ser-607, Ser-656 and Ser-720 as well as the N-terminal Ser-15 are sensitive to calcineurin-mediated dephosphorylation contributing to the modulation of the voltage-dependent gating properties. Dephosphorylation by phosphatase PTPRE confers neuroprotection by its inhibitory influence on the neuronal apoptotic potassium current surge in a Zn(2+)-dependent manner. Dephosphorylated at Ser-607 by protein phosphatase PPP1CA. Hypoxia-, seizure- or glutamate-induced neuronal activity promote calcium/calcineurin-dependent dephosphorylation resulting in a loss of KCNB1-containing clustering and enhanced channel activity. In response to brain ischemia, Ser-567 and Ser-607 are strongly dephosphorylated while Ser-457 and Ser-720 are less dephosphorylated. In response to brain seizures, phosphorylation levels on Ser-567 and Ser-607 are greatly reduced. Phosphorylated/dephosphorylated by Src or FYN tyrosine-protein kinases and tyrosine phosphatase PTPRE in primary Schwann cells and sciatic nerve tissue (By similarity).By Similarity
Acetylated. Acetylation occurs in pancreatic beta cells in response to stimulation by incretin hormones in a histone acetyltransferase (HAT)/histone deacetylase (HDAC)-dependent signaling pathway, promoting beta cell survival.By Similarity
Sumoylated on Lys-474, preferentially with SUMO1; sumoylation induces a positive shift in the voltage-dependence of activation and inhibits channel activity (PubMed:19223394).
Sumoylation increases the frequency of repetitive action potential firing at the cell surface of hippocampal neurons and decreases its frequency in pancreatic beta cells (PubMed:19223394).
Desumoylated by SENP1 (PubMed:19223394).

Bortolami, A., Yu, W., Forzisi, E., Ercan, K., Kadakia, R., Murugan, M., ... & Sesti, F. (2023). Integrin-KCNB1 potassium channel complexes regulate neocortical neuronal development and are implicated in epilepsy. Cell Death & Differentiation, 30(3), 687-701.

Bortolami, A., & Sesti, F. (2023). Ion channels in neurodevelopment: lessons from the Integrin-KCNB1 channel complex. Neural Regeneration Research, 18(11), 2365-2369.

Hiraide, T., Akita, T., Uematsu, K., Miyamoto, S., Nakashima, M., Sasaki, M., ... & Saitsu, H. (2023). A novel de novo KCNB1 variant altering channel characteristics in a patient with periventricular heterotopia, abnormal corpus callosum, and mild seizure outcome. Journal of Human Genetics, 68(1), 25-31.

Xiong, J., Liu, Z., Chen, S., Kessi, M., Chen, B., Duan, H., ... & Yin, F. (2022). Correlation analyses of clinical manifestations and variant effects in KCNB1-related neurodevelopmental disorder. Frontiers in Pediatrics, 9, 755344.

Hawkins, N. A., Misra, S. N., Jurado, M., Kang, S. K., Vierra, N. C., Nguyen, K., ... & Kearney, J. A. (2021). Epilepsy and neurobehavioral abnormalities in mice with a dominant-negative KCNB1 pathogenic variant. Neurobiology of disease, 147, 105141.

Bar, C., Barcia, G., Jennesson, M., Le Guyader, G., Schneider, A., Mignot, C., ... & Nabbout, R. (2020). Expanding the genetic and phenotypic relevance of KCNB1 variants in developmental and epileptic encephalopathies: 27 new patients and overview of the literature. Human mutation, 41(1), 69-80.

Bar, C., Kuchenbuch, M., Barcia, G., Schneider, A., Jennesson, M., Le Guyader, G., ... & Nabbout, R. (2020). Developmental and epilepsy spectrum of KCNB1 encephalopathy with long‐term outcome. Epilepsia, 61(11), 2461-2473.

Kang, S. K., Vanoye, C. G., Misra, S. N., Echevarria, D. M., Calhoun, J. D., O'Connor, J. B., ... & Kearney, J. A. (2019). Spectrum of KV2. 1 dysfunction in KCNB1‐associated neurodevelopmental disorders. Annals of neurology, 86(6), 899-912.

Yu, W., Zhang, H., Shin, M. R., & Sesti, F. (2019). Oxidation of KCNB1 potassium channels in the murine brain during aging is associated with cognitive impairment. Biochemical and biophysical research communications, 512(4), 665-669.

Wei, Y., Shin, M. R., & Sesti, F. (2018). Oxidation of KCNB1 channels in the human brain and in mouse model of Alzheimer’s disease. Cell death & disease, 9(8), 820.

Ask a question We look forward to hearing from you.
0 reviews or Q&As
Loading...
Have you used Mouse Anti-KCNB1 Recombinant Antibody (S89-34)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Documents

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

Go to
Compare